Paper3317828
Redesigning nature's poisons to create anti-tumor reagents.
Vitetta ES and 4 others. Science, 1987. Cited by 344 papers, by iCite.
Cite this record
ConductScience Library. Redesigning nature's poisons to create anti-tumor reagents. Papers, record 3317828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3317828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunotoxins | Major topic |
| Animals | |
| Antineoplastic Agents | |
| Clinical Trials as Topic | |
| Humans | |
| Neoplasms, Experimental | |
| Recombinant Proteins |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-28149 | NCI NIH HHS | United States | R01CA028149 | PubMed and NIH | NIH RePORTER |
| CA-41081 | NCI NIH HHS | United States | P01CA041081 | PubMed and NIH | NIH RePORTER |
| R37CA028149 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00001271 | A Phase I Study of Continuous Infusion Immunotoxin IgG-RFB4-SMPT-dgA in Refractory CD22 Positive B-Cell Lymphoma | Background |
Source ClinicalTrials.gov
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 344 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28451181 | Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates. | Chem Sci | 2017 | https://conductscience.org/library/papers/28451181 | PubMed |
| 19405947 | Development of a novel small antibody that retains specificity for tumor targeting. | J Exp Clin Cancer Res | 2009 | https://conductscience.org/library/papers/19405947 | PubMed |
| 14649886 | Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme. | J Neurooncol | 2003 | https://conductscience.org/library/papers/14649886 | PubMed |
| 12952291 | Immunotoxin therapy for CNS tumor. | J Neurooncol | 2003 | https://conductscience.org/library/papers/12952291 | PubMed |
| 12070352 | Design of protein struts for self-assembling nanoconstructs. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12070352 | PubMed |
| 11773976 | Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts. | Cancer Gene Ther | 2001 | https://conductscience.org/library/papers/11773976 | PubMed |
| 10677537 | Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10677537 | PubMed |
| 8580845 | Chemically crosslinked protein dimers: stability and denaturation effects. | Protein Sci | 1995 | https://conductscience.org/library/papers/8580845 | PubMed |
| 8421689 | A recombinant immunotoxin that is active on prostate cancer cells and that is composed of the Fv region of monoclonal antibody PR1 and a truncated form of Pseudomonas exotoxin. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8421689 | PubMed |
| 8419938 | Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8419938 | PubMed |
| 8234302 | Central oxytocin inhibition of salt appetite in rats: evidence for differential sensing of plasma sodium and osmolality. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8234302 | PubMed |
| 8190124 | Hormonotoxins: the role of positive charge of lysine residue on the immunological, biological and cytotoxic properties of ovine lutropin-S-S-gelonin conjugates. | Mol Cell Biochem | 1994 | https://conductscience.org/library/papers/8190124 | PubMed |
| 7927788 | Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin. | Infect Immun | 1994 | https://conductscience.org/library/papers/7927788 | PubMed |
| 7898459 | Diphtheria toxin-related cytokine fusion proteins: elongation factor 2 as a target for the treatment of neoplastic disease. | Mol Cell Biochem | 1994 | https://conductscience.org/library/papers/7898459 | PubMed |
| 7807185 | Immunotoxin therapy of leptomeningeal neoplasia. | J Neurooncol | 1994 | https://conductscience.org/library/papers/7807185 | PubMed |
| 7734325 | Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7734325 | PubMed |
| 7692443 | Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/7692443 | PubMed |
| 7683746 | Disulfide linked alpha oLH-gelonin conjugate failed to recombine with beta oLH subunit to generate bioeffective hormonotoxin. | Mol Cell Biochem | 1993 | https://conductscience.org/library/papers/7683746 | PubMed |
| 7619070 | Studies on crystal structures, active-centre geometry and depurinating mechanism of two ribosome-inactivating proteins. | Biochem J | 1995 | https://conductscience.org/library/papers/7619070 | PubMed |
| 7600567 | Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin. | Cancer Immunol Immunother | 1995 | https://conductscience.org/library/papers/7600567 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3317828
GET https://conductscience.org/api/papers/v1/3317828/cited_by?page=2